Baxter International | BAX - Cost Of Sales

Stock Price
18.33
Daily Change
0.54 3.04%
Monthly
-2.71%
Yearly
-41.74%
Q2 Forecast
16.95

Baxter International reported $1.81B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Abbott USD 5.3B 380M Mar/2026
AngioDynamics USD 37.29M 786K Sep/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 31.94M 3.22M Mar/2026
Avanos Medical USD 88M 6.9M Mar/2026
Baxter International USD 1.81B 587M Mar/2026
Becton, Dickinson and Co. USD 2.56B 281M Mar/2026
Boston Scientific USD 1.83B 8M Mar/2026
Cooper Companies USD 376.8M 87.4M Dec/2025
Dexcom USD 441.6M 25.3M Mar/2026
Edwards Lifesciences USD 362.6M 19.6M Mar/2026
Fresenius EUR 4.45B 262M Dec/2025
Globus Medical USD 263.59M 26.88M Mar/2026
Halozyme Therapeutics USD 108.75M 6.6M Mar/2026
ICU Medical USD 337.72M 1.61M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 232.7M 17.5M Mar/2026
Integra LifeSciences USD 178.71M 14.73M Mar/2026
Intuitive Surgical USD 940.3M 21.6M Mar/2026
J&J USD 8.07B 103M Mar/2026
Laboratory Of America USD 2.6B 4.2M Mar/2026
Masimo USD 152.8M 12.4M Mar/2026
Medtronic USD 3.61B 83M Dec/2025
Merit Medical Systems USD 197.08M 1.5M Mar/2026
Quest Diagnostics USD 1.99B 57M Mar/2026
Smith & Nephew USD 870M 17M Dec/2025
Stryker USD 2.36B 325M Mar/2026
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 240.84M 20.7M Mar/2026
Terumo JPY 151.3B 7.86B Mar/2026
Zimmer Biomet Holdings USD 738.3M 231.8M Mar/2026